Amphix Bio

Amphix Bio develops supramolecular peptide therapeutics that stimulate a patient's cells to initiate regenerative processes. Their platform technology is being used to create an off-the-shelf implant for spinal fusion surgeries, designed to provide a simpler and safer solution for treating back pain compared to existing methods.

Buy Funded Startups lists

Funding Round: Grant

Funding Amount: $1M

Date: 31-Oct-2024

Investors: National Science Foundation (NSF)

Markets: Regenerative Medicine, Biotech, Therapeutics

HQ: Chicago, Illinois, United States

Founded: 2021

Website: https://www.amphixbio.com/

LinkedIn: https://www.linkedin.com/company/amphix-bio

Twitter:

Instagram: